Skip to content

NSRX - Nasus Pharma Ltd - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Nasus Pharma Ltd.

NSRX · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NSRXNasus Pharma Ltd.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $9.99
52-wk low: $1.98
Prev close: $5.65
Mkt cap: $45.0M
P/B: 3.9x
Profit margin: +0.0%

Smart money

3 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

3 holders

Combined position$3.3M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$3.1M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $45M

Valuation

P/B3.89

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NSRX
Exchange: AMEX
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Market cap: $44.97M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-316.0%

$77K

position

JS

Jim Simons

Q2 2026 13F

$43K

position

Coverage gaps for NSRX

No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-316.0%

ROA-96.7%

Growth